Shichun Peng

机构：Feinstein Institute for Medical Research, Center for Neurosciences · ORCID：0000-0003-0653-636X

发表论文 56 篇 · 总被引 2133 次 · h-index 23

代表论文

• The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease (2022 · Cell Metabolism · 被引 315)
• Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease (2025 · Nature · 被引 133)
• The Age-Related Perfusion Pattern Measured With Arterial Spin Labeling MRI in Healthy Subjects (2018 · Frontiers in Aging Neuroscience · 被引 65)
• Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts (2018 · Human Brain Mapping · 被引 52)
• Dynamic 18 F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session (2021 · Journal of Nuclear Medicine · 被引 49)
• The identification and cognitive correlation of perfusion patterns measured with arterial spin labeling MRI in Alzheimer’s disease (2023 · Alzheimer s Research & Therapy · 被引 26)